E.O.R.T.C. phase II study of cisplatin in cyvadic-resistant soft tissue sarcoma

Eur J Cancer (1965). 1979 Dec;15(12):1511-3. doi: 10.1016/0014-2964(79)90032-x.
No abstract available

MeSH terms

  • Adult
  • Aged
  • Cisplatin / adverse effects
  • Cisplatin / therapeutic use*
  • Creatinine / blood
  • Drug Evaluation
  • Female
  • Hearing Loss, High-Frequency / chemically induced
  • Humans
  • Kidney Diseases / chemically induced
  • Male
  • Middle Aged
  • Sarcoma / drug therapy*
  • Soft Tissue Neoplasms / drug therapy*

Substances

  • Creatinine
  • Cisplatin